Intervention

paliperidone palmitate

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting0

Common conditions3

Lead sponsors shown8

Clinical trials

12 shown

The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With SchizophreniaNCT03080194 · 2017-04-01

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode SchizophreniaNCT01451736 · 2011-10-01

The Effect of Paliperidone Palmitate in SchizophreniaNCT01860781 · 2011-08-01

A Comparison of Long-acting Injectable Medications for SchizophreniaNCT01136772 · 2011-03-01

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)NCT01362426 · 2011-03-01

A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderNCT01193153 · 2010-09-01

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalNCT01193166 · 2010-08-01

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedNCT01157351 · 2010-05-01

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 YearsNCT00946985 · 2009-06-01

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With SchizophreniaNCT00119756 · 2005-06-01

A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With SchizophreniaNCT00210548 · 2005-04-01

A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With SchizophreniaNCT00210717 · 2005-02-01

Common conditions

Schizophrenia10 Schizoaffective Disorder2 Schizophrenia (Recent-onset)1

Leading sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3 Janssen Scientific Affairs, LLC2 Ortho-McNeil Janssen Scientific Affairs, LLC2 Janssen-Cilag Pty Ltd1 Maosheng Fang1 New York State Psychiatric Institute1 Seoul National University Hospital1 University of California, Los Angeles1

Trial status mix

COMPLETED9

TERMINATED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE47

PHASE34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.